Source : EMVision Medical Devices
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • EMVision Medical Devices (EMV) receives a total non-dilutive funding injection of $3.4 million
  • Following several cash receipts the company has cash reserves of approximately $10.3 million
  • Additional payments are reportedly still due to the company including a mile stone payment and outastanding contribution
  • Shares in the company are in the grey, trading at $2.58 at 1:20 pm AEDT

EMVision Medical Devices (EMV) receives a total non-dilutive funding injection of $3.4 million.

Following several cash receipts, the company has cash receives of approximately $10.3 million.

EMV is focused on the development and commercialisation of medical imaging technology.

The company is developing and seeking to commercialise a potentially cost-effective, portable, medical imaging device. According to the company the technology uses electromagnetic microwave imaging for diagnosis and monitoring of stroke and other medical applications

The company says it has received funding from a partner cash contribution with GE Healthcare which is a grant participant partner and collaborator. EMV has so far received $180 thousand from GE Healthcare with an additional $180 thousand outstanding.

Additionally EMV confirms it has received a cash rebate of just under $2 million from its R&D tax incentive claim for the financial year ending 30 June 2021.

The company also received $1.2 million in grant funding from the Australian Stroke Alliance (ASA) during the quarter. Earlier in the year the ASA along with the Medical Research Future Fund pledged $8 million to EMV.

The funding received to date represents the first two milestone payments due.

Shares in the company are in the grey, trading at $2.58 at 1:20 pm AEDT.

EMV by the numbers
More From The Market Online
The Market Online Video

Market Close: Green lights up on ASX for Easter hunt go

The ASX200 closed the day in record territory - nearly a per cent up with every…

Week 13 Wrap: Easter bunny delivers new all time high for ASX200

Another week, another all time high. The ASX200 clocked 7,901pts on Thursday for the first time…

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Market Update: ASX glows red hot with another hit record

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last…